. A schematic representation of holo-myoglobin with color coded helices, loops and termini, and the heme is shown in hot pink. The 1DWR crystal structure has been rotated 180° about the x-axis between the top and bottom structures. Figure 4 and Figure S2 for holo and apo forms, respectively. Figure S5 . Those residues that were found to have enhanced backbone cleavage frequencies upon UVPD activation are highlighted in red on the holo-myoglobin crystal structure 1DWR and in blue on the apomyoglobin structure. The heme group is shown as a hot pink color for holo-myoglobin. The 1DWR crystal structure has been rotated 180° about the x-axis between the top and bottom structures. The holomyoglobin crystal structure is used for the apo-protein to allow easy visualization of the regions that show enhanced UVPD fragmentation. Figure S6 . a) Holo-myoglobin fragmentation yields as reported in Figure 2 are presented for comparison with (b) the B-factors from holo-myoglobin crystal structure 1DWR along with (c) solvent accessibility data of both the backbone and side-chains calculated with GetArea. Regions are demarcated below (c). Solvent accessibility data was smoothed by box car averaging of two points.
